SecBot SecBot
Institutional Cluster

CRVS

Corvus Pharmaceuticals, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed5mo ago
Institutional cluster: 5 buyers, 1 sellers (bullish)
Actionable Insight • Neutral

This cluster is dominated by passive-index rebalancing (4 of 5 buyers are mega-passive), not active fundamental conviction, treat the signal as low conviction. Wait for a catalyst-linked active buyer or an actionable catalyst filing before acting.

DirectionNeutral
Confidencemedium
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$11.60
T+0 close · Jun 11, 2026 · via day close
Latest settled
+24.05%
T+60 · $14.39
Vs SPY
+19.66%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 11 $11.60entry
  2. T+1 · 5mo ago +2.84%α +2.30% · $11.93
  3. T+5 · 5mo ago +3.45%α +3.01% · $12.00
  4. T+20 · 4mo ago +39.66%α +37.76% · $16.20
  5. T+60 · 2mo ago +24.05%α +19.66% · $14.39

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

An institutional cluster formed in CRVS during 2025-Q3, with five institutions, including State Street, Fidelity, and Wellington, adding positions totaling $6.7M in net buying, while only Morgan Stanley trimmed its position.

Key Financial Metrics

Direction
accumulating
Buy Value
$10.2M
Sell Value
$3.6M
Net Flow
$6.7M

Institutional Positions

Net institutional flow: $6.7M

▲ Buyers (5)

InstitutionActionChangePosition ValueValue Δ
State StreetADD+51.4%$7.4M$4.8M
FidelityDOUBLED+529.1%$11.0K$10.0K
Wells FargoADD+34.4%$268.0K$160.0K
UBSADD+80.7%$1.2M$836.0K
Wellington Management GroupADD+76%$1.3M$919.0K

▼ Sellers (1)

InstitutionActionChangePrev ValueValue Δ
Morgan StanleyTRIM-31%$3.6M$971.0K

Key Facts

  • 5 institutional buyers added a net $6.7M in CRVS during Q3 2025
  • 4 of 5 buyers are mega-passive funds (State Street, Fidelity, Wells Fargo, UBS); only Wellington is an active asset manager
  • State Street alone added $4.8M, accounting for most of the net buying
  • Morgan Stanley trimmed 31% of shares but raw value increased due to share price appreciation
  • Ticker has 92% analyst buy/strong-buy rating and $938M market cap

Financial Impact

Institutional buyers added $6.7M in new holdings while one seller trimmed $971K in value (though dollar amount rose due to price), for net institutional accumulation of approximately $5.7M.

institutional ownership increasenet share accumulation

Risk Factors

  • 45-day 13F reporting lag, positions as of Sep 30, 2025 may have been fully unwound
  • Passive-dominated buying → no active fundamental thesis to trade against

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-CRVS-2025-Q3

Track record

15 reports on CRVS

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +2.61% at T+1 after the Mar 12, 2026 report. 2 of 3 went positive at some point.

Filters
  1. Nov 13, 20263d ago Insider Buy Neutral 3/10 Entry $11.20 settles Feb 12
  2. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $11.37 settles Feb 8
  3. Nov 5, 202611d ago 8-K Neutral 4/10 Entry $10.54 settles Feb 4
  4. Nov 5, 202611d ago Press Release Neutral 4/10 No price data
  5. Nov 4, 202612d ago Press Release Neutral 4/10 Entry $10.57 settles Feb 2
  6. Sep 30, 20266w ago Press Release Neutral 3/10 Entry $10.93 settles Dec 28
  7. Aug 21, 202612w ago Institutional Cluster Bullish 6/10 Entry $14.46 to $10.60 ▼ −26.69% −23.33% vs SPY
  8. Jul 22, 202616w ago 8-K Neutral 2/10 Entry $13.68 to $9.85 ▼ −28.00% −32.55% vs SPY
  9. Jun 11, 202622w ago Institutional Cluster Neutral 3/10 Viewing Entry $11.60 to $14.39 ▲ +24.05% +19.66% vs SPY
  10. May 14, 202626w ago 8-K Bullish 7/10 Entry $13.66 to $13.74 ▲ +0.62% −2.97% vs SPY
Showing 10 of 15

US Market Status

Market Closed · Opens in 6h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 11, 2026